JPH0816116B2 - 1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the same - Google Patents
1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the sameInfo
- Publication number
- JPH0816116B2 JPH0816116B2 JP1293196A JP29319689A JPH0816116B2 JP H0816116 B2 JPH0816116 B2 JP H0816116B2 JP 1293196 A JP1293196 A JP 1293196A JP 29319689 A JP29319689 A JP 29319689A JP H0816116 B2 JPH0816116 B2 JP H0816116B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- anhydrolactose
- hours
- reduced pressure
- hydroxyl groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LTYZUJSCZCPGHH-BNQXPIRTSA-N (2s,3r,4s,5r,6r)-2-[[(1s,2s,3r,4r,5s)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical class O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H]2OC[C@@H]1O2 LTYZUJSCZCPGHH-BNQXPIRTSA-N 0.000 title claims description 8
- 125000006239 protecting group Chemical group 0.000 title description 6
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 32
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 23
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- XPIJMQVLTXAGME-UHFFFAOYSA-N 1,1-dimethoxycyclohexane Chemical compound COC1(OC)CCCCC1 XPIJMQVLTXAGME-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 239000003377 acid catalyst Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000203 mixture Substances 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 11
- 239000008101 lactose Substances 0.000 description 11
- 229940125898 compound 5 Drugs 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 150000002597 lactoses Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- PNIWLNAGKUGXDO-UHFFFAOYSA-N Lactosamine Natural products OC1C(N)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 PNIWLNAGKUGXDO-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- DOVBXGDYENZJBJ-ONMPCKGSSA-N lactosamine Chemical compound O=C[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DOVBXGDYENZJBJ-ONMPCKGSSA-N 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- PNIWLNAGKUGXDO-LNCRCTFVSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical class O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 PNIWLNAGKUGXDO-LNCRCTFVSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 2
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 238000005907 ketalization reaction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- -1 lactose amine Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、N−アセチルラクトスアミン等のラクトー
ス誘導体の合成に有用である、選択的に保護基の導入さ
れた1,6−アンヒドロラクトース誘導体に関する。因み
に、ラクトースの誘導体はラクトスアミンなど生体内の
構成成分として非常に重要な働きをしており、また、ラ
クトスアミンは整腸作用を有する事が知られている。こ
のような重要な生理活性物質の合成中間体を提供する本
発明に係わる前記化合物は、工業的にも注目されている
化合物である。DETAILED DESCRIPTION OF THE INVENTION Industrial Field of the Invention The present invention is a 1,6-anhydro with selectively introduced protecting group, which is useful for the synthesis of lactose derivatives such as N-acetyllactosamine. It relates to a lactose derivative. Incidentally, a lactose derivative plays a very important role as a constituent in vivo such as lactosamine, and lactose amine is known to have an intestinal regulating action. The above-mentioned compound according to the present invention, which provides such an intermediate for the synthesis of an important physiologically active substance, is a compound that is also attracting industrial attention.
(従来の技術) ラクトースの選択的保護体としては、下記化学構造式
5,6及び7で示される化合物が知られている。すなわ
ち、手島らは、ラクトースの8個の水酸基のうち4個を
保護した化合物5を報告している(Chemistry and Phar
maceutical Bulletin,27巻 3号 721頁(1979))。T
hiemらも、8個の水酸基を酸性条件下で脱保護できるベ
ンジリデン基及び塩基性条件下で脱保護できるアセチル
基でそれぞれ保護した化合物6,7を報告している(J.Thi
em et al.Journal of Chemical Research,1980,2729-27
50(1980))。(Prior Art) As a selective protected form of lactose, the following chemical structural formula
The compounds represented by 5, 6 and 7 are known. That is, Teshima et al. Reported Compound 5 in which four of eight hydroxyl groups of lactose were protected (Chemistry and Phar.
Maceutical Bulletin, Vol. 27, No. 3, 721 (1979). T
hiem et al. also reported compounds 6 and 7 in which eight hydroxyl groups were protected with a benzylidene group that can be deprotected under acidic conditions and an acetyl group that can be deprotected under basic conditions (J. Thi.
em et al. Journal of Chemical Research, 1980, 2729-27
50 (1980)).
しかし、化合物5は4個の水酸基が残っているし、ま
た、化合物6,7も塩基性条件で保護基を脱離しても3個
以上の水酸基を有する化合物19,20,21,22となることが
予想され、ラクトースの8個の水酸基の内どれか1つに
選択的に反応を行なうことは非常に難しい。 However, compound 5 still has 4 hydroxyl groups, and compounds 6 and 7 are compounds 19, 20, 21, and 22 having 3 or more hydroxyl groups even if the protecting group is removed under basic conditions. Therefore, it is very difficult to selectively react with any one of the eight hydroxyl groups of lactose.
(発明が解決しようとする問題点) ラクトースは8個の水酸基を有している。この為ある
目的とするラクトースの誘導体をラクトースを出発原料
として合成する場合、この8個の水酸基を区別しながら
合成を進めなければならない。 (Problems to be Solved by the Invention) Lactose has eight hydroxyl groups. Therefore, when synthesizing a target lactose derivative using lactose as a starting material, it is necessary to proceed with the synthesis while distinguishing these eight hydroxyl groups.
たとえば、手島らは、ラクトスアミン誘導体を合成す
る為に、化合物5を出発原料として第1図に従ってラク
トスアミン誘導体9を合成している(前掲Chem.Pharm.B
ull.)。For example, Teshima et al. Synthesize a lactosamine derivative 9 according to FIG. 1 by using compound 5 as a starting material in order to synthesize a lactosamine derivative (Chem.Pharm.B, cited above).
ull.).
しかし、化合物5より化合物10を得る段階の収率は2
5.2%と低い。これは、化合物5では8個のラクトース
の水酸基の内4個の水酸基は保護されているものの、残
りの4個の水酸基は反応性にほとんど差がない為であ
る。この様に多くの水酸基を有するラクトースの誘導体
から目的とするラクトースの誘導体を効率よく合成する
には、これらの水酸基を選択的に保護し目的の水酸基の
みに反応を行なわなければならない。However, the yield in the step of obtaining compound 10 from compound 5 is 2
It is as low as 5.2%. This is because in compound 5, four of the eight hydroxyl groups of lactose are protected, but the remaining four hydroxyl groups have little difference in reactivity. In order to efficiently synthesize a desired lactose derivative from a lactose derivative having a large number of hydroxyl groups, it is necessary to selectively protect these hydroxyl groups and carry out the reaction only with the desired hydroxyl group.
そこで、本発明者らは、ラクトースを選択的に保護す
る方法を検討した結果、塩基性条件下で脱アセチルすれ
ば2個の水酸基のみが遊離で残りの6個の水酸基は保護
されている化合物1,4に容易に導くことができる化合物
2,3及び2個の水酸基のみが遊離である化合物1を得、
本発明をするに至った。Therefore, as a result of investigating a method of selectively protecting lactose, the present inventors have found that when deacetylated under basic conditions, only two hydroxyl groups are free and the remaining six hydroxyl groups are protected. Compounds that can easily lead to 1,4
To obtain compound 1 in which only 2,3 and 2 hydroxyl groups are free,
The present invention has been made.
(問題点を解決する為の手段) 1,6−アンヒドロラクトースは、ラクトースの還元末
端とグルコースの6位の2個の水酸基を保護した化合物
と考えられる。またこの環構造は、トリフルオロ酢酸等
の酸によってもとの水酸基を有する化合物へ戻す事がで
きる。 (Means for Solving Problems) It is considered that 1,6-anhydrolactose is a compound in which the reducing terminal of lactose and the two hydroxyl groups at the 6-position of glucose are protected. Further, this ring structure can be restored to the original compound having a hydroxyl group by an acid such as trifluoroacetic acid.
一方ケタール及びアセタールは糖化合物の4位と6位
を選択的に保護する酸性条件下で脱保護できる保護基と
して知られている。On the other hand, ketals and acetals are known as protecting groups that can be deprotected under acidic conditions that selectively protect the 4- and 6-positions of sugar compounds.
1,6−アンヒドロラクトース及びアセタールを組み合
わせた化合物として化合物5が知られている。しかし、
この化合物は、前述のように4個の水酸基を有しており
この4個の水酸基の反応性を利用してラクトスアミン等
の合成を進めるのは非常に困難である。手島らは化合物
5にトシルクロリドを作用させてラクトスアミンの合成
原料である化合物10を得ているが収率は前述のように2
5.2%と非常に低い事を報告している(前掲Chem.Pharm.
Bull.)。Compound 5 is known as a compound in which 1,6-anhydrolactose and acetal are combined. But,
This compound has four hydroxyl groups as described above, and it is very difficult to proceed with the synthesis of lactosamine and the like by utilizing the reactivity of these four hydroxyl groups. Teshima et al. Obtained a compound 10 which is a synthetic raw material of lactosamine by reacting compound 5 with tosyl chloride.
It is reported to be very low at 5.2% (Chem.Pharm.
Bull.).
そこで本発明者らは、1,6−アンヒドロラクトースの
6個の水酸基の内4個をケタールで選択的に保護するこ
とを検討した。すなわち、構造式8で示される公知化合
物1,6−アンヒドロラクトースに於てグルコース部分の
2個の水酸基は1,6−アンヒドロ環の形成によりガラク
トース部分とは逆の立体配座をとっていると考えられる
ので、アセタール化もしくはケタール化を行なうことは
できないと考えられる。Therefore, the present inventors studied to selectively protect 4 out of 6 hydroxyl groups of 1,6-anhydrolactose with a ketal. That is, in the known compound 1,6-anhydrolactose represented by the structural formula 8, the two hydroxyl groups of the glucose moiety have the opposite conformation to the galactose moiety due to the formation of the 1,6-anhydro ring. Therefore, it is considered that acetalization or ketalization cannot be performed.
そこで化合物8に、ジメチルホルムアミド中、触媒量
のカンファースルホン酸存在下、1,1−ジメトキシシク
ロヘキサンを減圧下反応させた後、得られた反応混合物
をピリジン及び無水酢酸でアセチル化したところ、目的
とする化合物2が得られた。また、反応温度を上げ減圧
度を下げると化合物3が得られることも見いだした。さ
らに反応させる1,1−ジメトキシシクロヘキサンの量、
反応温度、反応時間及び減圧度などの反応条件を検討し
た。その結果、化合物2を得るためには1,1−ジメトキ
シシクロヘキサンの量として2〜9倍モル量好ましくは
3.3〜7.5倍モル量、減圧度として10〜100mmHg好ましく
は25〜50mmHg、反応温度として40〜70℃望ましくは45〜
55℃、反応時間として0.5〜10時間好ましくは3〜6時
間が好適であった。また化合物3を得るためには、1,1
−ジメトキシシクロヘキサンの量として2〜12倍モル量
好ましくは4〜7倍モル量、減圧度として10〜250mmHg
望ましくは50〜160mmHg、反応温度として70〜120℃望ま
しくは80〜110℃、反応時間として1〜10時間望ましく
は6〜9時間が好適であった。また触媒として用いる酸
としては、カンファースルホン酸、パラトルエンスルホ
ン酸、メタンスルホン酸が好適であった。 Then, the compound 8 was reacted with 1,1-dimethoxycyclohexane under reduced pressure in the presence of a catalytic amount of camphorsulfonic acid in dimethylformamide, and the obtained reaction mixture was acetylated with pyridine and acetic anhydride. Compound 2 was obtained. It was also found that compound 3 was obtained by increasing the reaction temperature and decreasing the degree of vacuum. The amount of 1,1-dimethoxycyclohexane to be further reacted,
Reaction conditions such as reaction temperature, reaction time and degree of vacuum were examined. As a result, in order to obtain compound 2, the molar amount of 1,1-dimethoxycyclohexane is preferably 2 to 9 times,
3.3 to 7.5 times the molar amount, the degree of vacuum is 10 to 100 mmHg, preferably 25 to 50 mmHg, and the reaction temperature is 40 to 70 ° C, desirably 45 to
The reaction time at 55 ° C. was 0.5 to 10 hours, preferably 3 to 6 hours. To obtain compound 3, 1,1
-The amount of dimethoxycyclohexane is 2 to 12 times, preferably 4 to 7 times, and the degree of reduced pressure is 10 to 250 mmHg.
Desirably, the reaction temperature was 70 to 120 ° C., preferably 80 to 110 ° C., the reaction time was 1 to 10 hours, preferably 6 to 9 hours. Moreover, camphorsulfonic acid, paratoluenesulfonic acid, and methanesulfonic acid were suitable as the acid used as the catalyst.
化合物2及び3はトリフルオロ酢酸などの強酸で脱保
護される1,6−アンヒドロ環、酢酸などの弱酸で脱保護
される2個のケタール基、および塩基性で脱保護される
アセチル基の3種類の保護基によって選択的に8個の水
酸基の全部又は殆んど全部が保護されたラクトースの選
択的保護体であり、また、化合物1は2個の水酸基のみ
が遊離で他の6個の水酸基は全て保護されているため、
各種ラクトース誘導体の合成中間体として有用である。Compounds 2 and 3 are 1,6-anhydro ring deprotected by a strong acid such as trifluoroacetic acid, two ketal groups deprotected by a weak acid such as acetic acid, and an acetyl group deprotected by a basic acid. It is a selective protected form of lactose in which all or almost all of the eight hydroxyl groups are selectively protected by various kinds of protecting groups, and the compound 1 has only two hydroxyl groups free and the other six groups. Since all the hydroxyl groups are protected,
It is useful as a synthetic intermediate for various lactose derivatives.
以下、実施例により本発明を更に説明する。 Hereinafter, the present invention will be further described with reference to examples.
実施例1(化合物2の合成) 化合物8(1100mg)、1,1−ジメトキシシクロヘキサ
ン(1.61g)、ジメチルホルムアミド(20ml)及びカン
ファースルフォン酸(30mg)を50mmHgの減圧下3.5時間5
0℃にて加熱した。得られた溶液を室温まで冷却し無水
重炭酸ソーダを加え30分撹拌し結晶をろ過した。濾液を
減圧下濃縮しピリジン(10ml)、無水酢酸(10ml)を加
え室温下一昼夜撹拌した。得られた溶液を氷水に加えジ
クロルメタンで抽出した。有機層を2N塩酸、飽和重炭酸
ソーダ水溶液、次いで水で洗浄した。Example 1 (Synthesis of Compound 2) Compound 8 (1100 mg), 1,1-dimethoxycyclohexane (1.61 g), dimethylformamide (20 ml) and camphorsulfonic acid (30 mg) were reduced under a reduced pressure of 50 mmHg for 3.5 hours 5
Heated at 0 ° C. The resulting solution was cooled to room temperature, anhydrous sodium bicarbonate was added, and the mixture was stirred for 30 minutes and the crystals were filtered. The filtrate was concentrated under reduced pressure, pyridine (10 ml) and acetic anhydride (10 ml) were added, and the mixture was stirred at room temperature for 24 hours. The resulting solution was added to ice water and extracted with dichloromethane. The organic layer was washed with 2N hydrochloric acid, saturated aqueous sodium bicarbonate solution, and then water.
溶媒を減圧下留去しシリカゲルカラムクロマトグラフ
ィーにて分離し(溶離液トルエン:酢酸エチル=5:
1)、化合物2を得た。The solvent was evaporated under reduced pressure and the residue was separated by silica gel column chromatography (eluent toluene: ethyl acetate = 5:
1), Compound 2 was obtained.
収量 650mg、収率34%、 [α]D=−36°(C=0.50,クロロホルム)。Yield 650 mg, yield 34%, [[alpha]] D = -36 [deg.] (C = 0.50, chloroform).
元素分析:計算値C:59.15,H:7.09 実施値C:59.20,H:7.09 NMR(CDCL3)δ(ppm);1.17-1.80(m,20H,H-cyclohexy
l)、2.11(s,3H,OAc)、2.22(s,3H,OAc)、3.36(s,3
H,OAc)、3.48(dd,1H,H-3′)、3.52(s,1H,H-4)、3.
79-4/06(m,4H,H-6ab,H-6′ab)、4.12(t,1H,H-
2′)、4.40(broad s,1H,H-4′)、4.53(s,1H,H-
3)、4.81(broad d,1H,H-5)、4.87(d,1H,H-1′)、
5.50(s,1H,H-2)、5.64(s,1H,H-1)。Elemental analysis: Calculated value C: 59.15, H: 7.09 Actual value C: 59.20, H: 7.09 NMR (CDCL3) δ (ppm); 1.17-1.80 (m, 20H, H-cyclohexy
l), 2.11 (s, 3H, OAc), 2.22 (s, 3H, OAc), 3.36 (s, 3
H, OAc), 3.48 (dd, 1H, H-3 '), 3.52 (s, 1H, H-4), 3.
79-4 / 06 (m, 4H, H-6ab, H-6′ab), 4.12 (t, 1H, H-
2 '), 4.40 (broad s, 1H, H-4'), 4.53 (s, 1H, H-
3), 4.81 (broad d, 1H, H-5), 4.87 (d, 1H, H-1 '),
5.50 (s, 1H, H-2), 5.64 (s, 1H, H-1).
実施例2(化合物3の合成) 化合物8(550mg)、1,1−ジメトキシシクロヘキサン
(1.46g)、ジメチルホルムアミド(15ml)及びカンフ
ァースルフォン酸(10mg)を160mmHgの減圧下2時間110
℃で、さらに70mmHgの減圧下6時間90℃で加熱した。得
られた溶液を室温まで冷却し無水重炭酸ソーダを加え30
分撹拌し結晶をろ過した。濾液を減圧下濃縮しピリジン
(10ml)、無水酢酸(10ml)を加え室温下一昼夜撹拌し
た。得られた溶液を氷水に加えジクロルメタンで抽出し
た。有機層を2N塩酸、飽和重炭酸ソーダ水溶液、次いで
水で洗浄した。Example 2 (Synthesis of Compound 3) Compound 8 (550 mg), 1,1-dimethoxycyclohexane (1.46 g), dimethylformamide (15 ml) and camphor sulfonic acid (10 mg) under reduced pressure of 160 mmHg for 2 hours 110.
The mixture was further heated at 90 ° C. under reduced pressure of 70 mmHg for 6 hours. Cool the resulting solution to room temperature and add anhydrous sodium bicarbonate 30
The mixture was stirred for minutes and the crystals were filtered. The filtrate was concentrated under reduced pressure, pyridine (10 ml) and acetic anhydride (10 ml) were added, and the mixture was stirred at room temperature for 24 hours. The resulting solution was added to ice water and extracted with dichloromethane. The organic layer was washed with 2N hydrochloric acid, saturated aqueous sodium bicarbonate solution, and then water.
溶媒を減圧下留去しシリカゲルカラムクロマトグラフ
ィーにて分離し化合物3を得た。The solvent was evaporated under reduced pressure and the residue was separated by silica gel column chromatography to obtain compound 3.
収量326mg、収率33.8%、[α]D=+54° (c=0.76、クロロホルム)、融点210〜211℃(クロロ
フォルム)。Yield 326 mg, yield 33.8%, [α] D = + 54 ° (c = 0.76, chloroform), melting point 210-211 ° C. (chloroform).
元素分析:計算値C:59.15,H:7.09 実施値C:59.19,H:7.13 NMR(CDCl3)δ(ppm);1.25-1.86(m,10H,H-H-cyclohe
xyl)、2.10(s,6H,OAc)、3.73-3.78(m,3H,H-2′,H-
4,H-6)、3.76(dd,H-4,H-6と重複)、3.84(broad s,1
H,H-6)、3.91(dd,J3,4,6.4Hz,t,1H,H-3)、4.03(m,1
H,H-5′)、4.08(dd,1H,H-3′)、4.14(dd,1H,H-
4′)、4.28(dd,1H,H-6′)、4.40(dd,1H,H-6′)、
4.43(d,1H,H-1′)、4.54(d,J2,3,7.6Hz,1H,H-2)、
4.52(broad d,1H,H-5)、5.25(s,1H,H-1)。Elemental analysis: Calculated value C: 59.15, H: 7.09 Actual value C: 59.19, H: 7.13 NMR (CDCl3) δ (ppm); 1.25-1.86 (m, 10H, HH-cyclohe
xyl), 2.10 (s, 6H, OAc), 3.73-3.78 (m, 3H, H-2 ′, H-
4, H-6), 3.76 (duplicate with dd, H-4, H-6), 3.84 (broad s, 1
H, H-6), 3.91 (dd, J 3,4, 6.4Hz, t, 1H, H-3), 4.03 (m, 1
H, H-5 '), 4.08 (dd, 1H, H-3'), 4.14 (dd, 1H, H-
4 '), 4.28 (dd, 1H, H-6'), 4.40 (dd, 1H, H-6 '),
4.43 (d, 1H, H- 1 '), 4.54 (d, J 2,3, 7.6Hz, 1H, H-2),
4.52 (broad d, 1H, H-5), 5.25 (s, 1H, H-1).
実施例3(化合物2の合成) 化合物8(550mg)、1,1-ジメトキシシクロヘキサン
(1.83g)、DMF(10ml)及びカンファースルフォン酸
(30mg)を実施例1と同様に50℃、25mmHgにて6時間反
応させ、実施例1と同様に分離したところ、化合物2が
得られた。Example 3 (Synthesis of Compound 2) Compound 8 (550 mg), 1,1-dimethoxycyclohexane (1.83 g), DMF (10 ml) and camphor sulfonic acid (30 mg) were prepared at 50 ° C. and 25 mmHg in the same manner as in Example 1. After reacting for 6 hours and separating in the same manner as in Example 1, Compound 2 was obtained.
収量469mg,収率48.6%。 Yield 469 mg, yield 48.6%.
実施例4(化合物1の合成) 化合物2(568mg)のメタノール溶液(10ml)にナト
リウムメチラートのメタノール溶液(5M/l,0.02ml)を
加え、室温で5時間撹拌した。溶液にH+型イオン交換樹
脂(Dowex 50W-X8)を加えて中和した後樹脂を過し、
溶媒を減圧下留去した。残渣をエタノール−クロロホル
ム混合溶媒で再結晶し、化合物1を得た。Example 4 (Synthesis of Compound 1) A methanol solution of sodium methylate (5 M / l, 0.02 ml) was added to a methanol solution (10 ml) of compound 2 (568 mg), and the mixture was stirred at room temperature for 5 hours. Add H + type ion exchange resin (Dowex 50W-X8) to the solution to neutralize it, then pass the resin through,
The solvent was distilled off under reduced pressure. The residue was recrystallized with a mixed solvent of ethanol-chloroform to obtain compound 1.
収量387mg、収率80%、[α]D=−58° (C=0.83、メタノール)、融点218〜220℃。Yield 387 mg, yield 80%, [α] D = -58 ° (C = 0.83, methanol), melting point 218-220 ° C.
元素分析:計算値C:59.49,H:7.49 実施値C:59.48,H:7.38 参考例1 化合物3(484mg)のメタノール溶液(10ml)に5モ
ル/lのナトリウムメチラートのメタノール溶液(0.05m
l)を加え、5時間室温で攪拌した。得られた溶液にH+
型強酸性樹脂50W-X8を加え中和した。樹脂を過し、溶
媒を減圧下留去した。Elemental analysis: Calculated value C: 59.49, H: 7.49 Actual value C: 59.48, H: 7.38 Reference Example 1 5 mol / l sodium methylate in methanol solution (0.05m) in methanol solution (10ml) of compound 3 (484mg)
l) was added and the mixture was stirred for 5 hours at room temperature. H + in the resulting solution
Type strong acid resin 50W-X8 was added to neutralize. The resin was passed through and the solvent was distilled off under reduced pressure.
残渣に無水ピリジン(10ml)、トリチルクロリド(28
0mg)を加え、2時間攪拌した後、p−トルエンスルホ
ン酸クロリド(194mg)を加え、さらに4時間攪拌し
た。得られた溶液を氷水(20g)に加え、クロロホルム
(100ml)にて抽出した。クロロホルム層を2N塩酸、飽
和重炭酸ナトリウム水溶液、水の順で洗い、無水硫酸ナ
トリウムにて乾燥した。Anhydrous pyridine (10 ml) and trityl chloride (28
(0 mg) was added and the mixture was stirred for 2 hours, p-toluenesulfonic acid chloride (194 mg) was added, and the mixture was further stirred for 4 hours. The resulting solution was added to ice water (20 g) and extracted with chloroform (100 ml). The chloroform layer was washed with 2N hydrochloric acid, a saturated aqueous solution of sodium bicarbonate and water in this order, and dried over anhydrous sodium sulfate.
残渣にメタノール(20ml),カンファースルフォン酸
(10mg)を加え、室温で10時間攪拌した。Methanol (20 ml) and camphorsulfonic acid (10 mg) were added to the residue, and the mixture was stirred at room temperature for 10 hours.
得られた溶液にピリジン(10ml)、ナトリウムメチラ
ートのメタノール溶液(5M/l,0.210ml)を加え、一晩攪
拌した。Pyridine (10 ml) and a sodium methylate methanol solution (5 M / l, 0.210 ml) were added to the obtained solution, and the mixture was stirred overnight.
得られた溶液を氷酢酸で中和した後、溶媒を減圧下留
去し、残渣を水(50ml)、メチレンクロリド(50ml)で
抽出した。メチレンクロリド層を1N塩酸、飽和重炭酸ナ
トリウム水溶液、水で洗浄し、無水硫酸ナトリウムで乾
燥した。The resulting solution was neutralized with glacial acetic acid, the solvent was evaporated under reduced pressure, and the residue was extracted with water (50 ml) and methylene chloride (50 ml). The methylene chloride layer was washed with 1N hydrochloric acid, saturated aqueous sodium bicarbonate solution, water, and dried over anhydrous sodium sulfate.
溶媒を減圧下留去し、残渣にアジ化ナトリウム(300m
g)とジメチルホルムアミド(30ml)を加え、 110℃で48時間加熱した。溶媒を減圧下留去し、残渣
にクロロホルム(200ml)と水(200ml)を加え、抽出し
たクロロホルム層を無水硫酸ナトリウムで乾燥し、溶媒
を減圧下留去した。残渣に硫酸:無水酢酸:酢酸=(1:
70:30容量比)の混合物(10ml)を加え、室温で15時間
攪拌した。得られた溶液を参考例2と同様に処理し、化
合物13を232mg得た。収率35%。The solvent was distilled off under reduced pressure, and sodium azide (300 m
g) and dimethylformamide (30 ml) were added, and the mixture was heated at 110 ° C for 48 hours. The solvent was evaporated under reduced pressure, chloroform (200 ml) and water (200 ml) were added to the residue, the extracted chloroform layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. Sulfuric acid: acetic anhydride: acetic acid = (1:
The mixture (10 ml) of 70:30 by volume) was added, and the mixture was stirred at room temperature for 15 hours. The obtained solution was treated in the same manner as in Reference Example 2 to obtain 232 mg of compound 13. Yield 35%.
さらに、化合物13を後出参考例2と同様に処理すれ
ば、化合物9が得られる。Further, by treating the compound 13 in the same manner as in Reference Example 2 described later, the compound 9 is obtained.
以上の反応のフローチャートを第2図に示す。 A flowchart of the above reaction is shown in FIG.
参考例2 化合物1(485mg)のジクロロメタン溶液(10ml)
に、無水トリフルオロメタンスルホン酸(290mg)を加
え、室温下4時間攪拌した。Reference Example 2 Compound 1 (485 mg) in dichloromethane solution (10 ml)
To the above, trifluoromethanesulfonic anhydride (290 mg) was added, and the mixture was stirred at room temperature for 4 hours.
得られた溶液を減圧下留去し残渣にアジ化ナトリウム
(300mg)とヂメチルホルムアミド(20ml)を加え110℃
で48時間加熱攪拌した。得られた溶液に水(50ml)を加
えクロロホルム(100ml)で抽出し、クロロホルム層を
無水硫酸ナトリウムで乾燥した。The resulting solution was evaporated under reduced pressure, sodium azide (300 mg) and dimethylformamide (20 ml) were added to the residue, and the temperature was 110 ° C.
The mixture was heated and stirred for 48 hours. Water (50 ml) was added to the obtained solution, extraction was performed with chloroform (100 ml), and the chloroform layer was dried over anhydrous sodium sulfate.
溶媒を減圧下留去し、残渣に硫酸:無水酢酸:酢酸=
(1:70:30容量比)の混合物(10ml)を加え室温下4時
間撹拌した。残渣を氷水200gに加えクロロホルム100ml
で抽出した。クロロホルム層を飽和重炭酸ナトリウム水
溶液、水で洗浄し、無水硫酸ナトリウムで乾燥した。ク
ロロホルムを減圧した留去しシリカゲルカラムクロマト
グラフィーで分離して化合物13(397mg)を得た。収率6
0%。The solvent was distilled off under reduced pressure, and the residue was sulfuric acid: acetic anhydride: acetic acid =
A mixture (10 ml) of (1:70:30 volume ratio) was added, and the mixture was stirred at room temperature for 4 hours. Add the residue to 200 g of ice water and 100 ml of chloroform.
It was extracted with. The chloroform layer was washed with saturated aqueous sodium bicarbonate solution and water, and dried over anhydrous sodium sulfate. Chloroform was distilled off under reduced pressure and the residue was separated by silica gel column chromatography to obtain compound 13 (397 mg). Yield 6
0%.
化合物13を手島らの方法前出(Chemistry and Pharma
ceutical Bulletin,27巻 3号 721頁(1979))に従
いラネーニッケルで還元しさらに無水酢酸でアセチル化
し化合物9すなわちN−アセチルラクトスアミンのアセ
チル体を94%の収率で得た。Compound 13 was prepared by the method of Teshima et al. (Chemistry and Pharma
Ceutical Bulletin, Vol. 27, No. 3, p. 721 (1979), reduction with Raney nickel and acetylation with acetic anhydride were carried out to obtain Compound 9, that is, the acetyl derivative of N-acetyllactosamine, in a yield of 94%.
以上の反応のフローチャートを第3図に示す。 A flowchart of the above reaction is shown in FIG.
参考例1および参考例2で、化合物1および化合物3
から出発して化合物9を合成した時の合計の収率は、そ
れぞれ0.60×0.94×100=56.4%及び0.35×0.94×100=
32.9%に対し、手島らの方法では化合物5から出発して
同じく化合物9を合成したときの合計収率は7.3%に過
ぎない。なるほど両者で出発原料が異なるが、手島らの
方法で化合物5から化合物10を合成する段階の収率が2
5.2%と極端に低くなっている事を考慮すれば、本参考
例の方法が顕著に優れている。In Reference Example 1 and Reference Example 2, compound 1 and compound 3
When the compound 9 was synthesized starting from, the total yield was 0.60 × 0.94 × 100 = 56.4% and 0.35 × 0.94 × 100 =
In contrast to 32.9%, according to the method of Teshima et al., The total yield when starting from compound 5 and similarly synthesizing compound 9, is only 7.3%. Although the starting materials differ for both, the yield of the step of synthesizing compound 5 from compound 5 by the method of Teshima et al.
Considering that it is extremely low at 5.2%, the method of this reference example is remarkably excellent.
実施例1〜3の様な1,1−ジメトキシシクロヘキサン
によるケタール交換反応を用いるケタール化は、1,1−
ジメトキシシクロヘキサンを過剰に用いると種々の化合
物が生成すると考えられており、実用化されていなかっ
た。しかし、本発明者らは、反応の際の温度と減圧度を
制御することにより化合物2及び3が選択的に得られこ
とを見出した。一方、化合物2及び3は、塩基性条件下
(例えば、メタノール中触媒量のナトリウムメチラー
ト)で処理することにより、2個の水酸基のみが遊離と
なった化合物1及び4に容易に導くことができる。化合
物1及び4は、反応し得る水酸基は2個のみでその他の
水酸基はすべて保護されているので、参考例1及び2の
ように、ラクトースの2位の水酸基のみに反応を行なう
場合高収率で2位のみを修飾できる。これより、本発明
の化合物1,2及び3は、ラクトース誘導体の合成中間体
として非常に有用であることがわかる。Ketalization using a ketal exchange reaction with 1,1-dimethoxycyclohexane as in Examples 1 to 3,
It is considered that various compounds are produced when dimethoxycyclohexane is used in excess, and it has not been put to practical use. However, the present inventors have found that compounds 2 and 3 are selectively obtained by controlling the temperature and the degree of reduced pressure during the reaction. On the other hand, Compounds 2 and 3 can be easily led to Compounds 1 and 4 in which only two hydroxyl groups are released by treating them under basic conditions (for example, a catalytic amount of sodium methylate in methanol). it can. Compounds 1 and 4 have only two reactable hydroxyl groups and all other hydroxyl groups are protected, so that when the reaction is performed only on the 2-position hydroxyl group of lactose as in Reference Examples 1 and 2, a high yield is obtained. Only the 2nd position can be modified with. From this, it is understood that the compounds 1, 2 and 3 of the present invention are very useful as synthetic intermediates for lactose derivatives.
(発明の効果) 例えば重要な生理活性を有する物質であるラクトスア
ミンを高収率に容易に与える、選択的に保護基の導入さ
れた該ラクトスアミンの優れた中間体である1,6−アン
ヒドロラクトース誘導体が提供される。(Effects of the Invention) For example, 1,6-anhydrolactose, which is an excellent intermediate of lactosamine to which a protective group is selectively introduced, can easily give lactosamine, which is a substance having important physiological activity, in high yield. Derivatives are provided.
第1図は公知のラクトスアミン誘導体の合成反応のフロ
ーチャートであり、第2図及び第3図は、それぞれ、参
考例1及び2の反応のフローチャートである。FIG. 1 is a flowchart of a synthetic reaction of a known lactosamine derivative, and FIGS. 2 and 3 are flowcharts of reactions of Reference Examples 1 and 2, respectively.
Claims (3)
される1,6−アンヒドロラクトース誘導体。 1. A 1,6-anhydrolactose derivative represented by any one of the following chemical structural formulas 1, 2 and 3.
下ジメチルフォルムアミド中で2〜9倍モル量の1,1−
ジメトキシシクロヘキサンと10〜100mmHgの減圧下で40
〜70℃に0.5〜10時間加熱した後、ピリジン及び無水酢
酸でアセチル化することを特徴とする、請求項1に記載
の化学構造式2で示される化合物の合成方法。2. A 1 to 9-fold molar amount of 1,6-anhydrolactose in dimethylformamide in the presence of an acid catalyst.
40 with dimethoxycyclohexane and a reduced pressure of 10 to 100 mmHg
The method for synthesizing the compound represented by the chemical formula 2 according to claim 1, wherein the compound is heated to ˜70 ° C. for 0.5 to 10 hours and then acetylated with pyridine and acetic anhydride.
下ジメチルフォルムアミド中で2〜12倍モル量の1,1−
ジメトキシシクロヘキサンと10〜250mmHgの減圧下で70
〜120℃に1〜10時間加熱した後、ビリジン及び無水酢
酸でアセチル化することを特徴とする、請求項1に記載
の化学構造式3で示される化合物の合成方法。3. A 2- to 12-fold molar amount of 1,1-anhydrolactose in dimethylformamide in the presence of an acid catalyst.
Dimethoxycyclohexane and 70 under reduced pressure of 10-250 mmHg
The method for synthesizing the compound represented by the chemical formula 3 according to claim 1, wherein the compound is heated to ˜120 ° C. for 1 to 10 hours and then acetylated with pyridine and acetic anhydride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1293196A JPH0816116B2 (en) | 1989-11-10 | 1989-11-10 | 1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1293196A JPH0816116B2 (en) | 1989-11-10 | 1989-11-10 | 1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03153696A JPH03153696A (en) | 1991-07-01 |
| JPH0816116B2 true JPH0816116B2 (en) | 1996-02-21 |
Family
ID=17791663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1293196A Expired - Lifetime JPH0816116B2 (en) | 1989-11-10 | 1989-11-10 | 1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0816116B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2016367B1 (en) * | 2016-03-04 | 2017-09-19 | Phenom-World Holding B V | Scanning electron microscope |
-
1989
- 1989-11-10 JP JP1293196A patent/JPH0816116B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03153696A (en) | 1991-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Neilson et al. | Oligoribonucleotide Synthesis. II. Preparation of 2′-O-tetrahydropyranyl Derivatives of Adenosine and Cytidine Necessary for Insertion in Stepwise Synthesis | |
| JP2546659B2 (en) | Method for producing podophyllotoxin type compound | |
| EP0141057A1 (en) | Novel 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments | |
| JPS6345293A (en) | Sialosylceramide compound and production thereof | |
| KR20040021670A (en) | Process for the preparation of ribavirin | |
| HU205133B (en) | Process for producing epipodophyllotoxin altroside derivatives and pharmaceutical compositions comprising same | |
| KR920002146B1 (en) | Method for preparing thiogogenin beta-cellobiose glycosides and intermediates used in the method | |
| HU205132B (en) | Process for producing fluorine-substituted epipodophyllotoxin glycosides and pharmaceutical compositions comprising same as active ingredient | |
| HU198505B (en) | Process for producing antitumour anthracycline glycosides | |
| JPH0660191B2 (en) | Novel anthracycline lycosides, method for producing them, and antitumor agent containing them | |
| JPH0816116B2 (en) | 1,6-Anhydrolactose derivative with selectively introduced protecting group and method for producing the same | |
| US6384201B1 (en) | Synthetic method for the preparation of the antineoplastic agent etoposide | |
| US8524873B2 (en) | Sugar donor | |
| US3445455A (en) | L-lyxopyranosyloxy-alkylcoumarin-containing glycosides | |
| AU641644B2 (en) | A process for the preparation of etoposides | |
| CN115505017A (en) | Synthesis method of etoposide and analogues thereof | |
| CN110016066B (en) | A kind of synthetic method of I type N-glycan antenna | |
| KR101259648B1 (en) | A manufacturing process of 2′,2′-difluoronucloside and intermediate | |
| CN110041377B (en) | A kind of synthetic method of O-mannan core structure | |
| CN116199698A (en) | Functionalized D-glucal compound and preparation method thereof | |
| JPS6152839B2 (en) | ||
| JPH0543545A (en) | New aza-saccharide derivative | |
| CN115611913A (en) | A kind of synthetic method of natural product ScleropentasideD | |
| CN121824650A (en) | A four-step preparation method for gentiopicrin amide derivatives and its application | |
| JPH02295996A (en) | Preparation of glucosaminyl-epi-podophyllotoxin derivative |